Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry.
Joanne N Davis, Clinton Medbery, Sanjeev Sharma...
https://pubmed.ncbi.nlm.nih.gov/25774243/Actively Recruiting
Led by The Radiosurgery Society · Updated on 2024-09-19
50000
Participants Needed
13
Research Sites
N/A
Total Duration
This research aims to collect and analyze long-term data on the use of Stereotactic Radiosurgery SRS and Stereotactic Body Radiation Therapy SBRT in treating patients with life-threatening tumors and other medical conditions. The study is an international, multi-year observational registry designed to understand how these treatments are used and their outcomes in everyday clinical practice. It continues the work of a prior study focused on CyberKnife treatment and is sponsored by The Radiosurgery Society. Participants in this study include patients with various conditions considered treatable by SRS or SBRT. The study captures information such as patient characteristics, disease details, treatment plans, and outcomes. This data collection allows participating sites to track treatment effectiveness and share their experiences. The registry is maintained by Vision Tree, Inc., which ensures data security and compliance with privacy regulations. Both prospective and some retrospective patient data are included. During the study, participants treatment outcomes are monitored over time, including overall survival for up to five years and local or distant recurrence within one to five years. The registry allows detailed recording of outcomes specific to each condition treated. Patients provide consent to participate, and their data contributes to improving understanding of these advanced radiation therapies. The total duration of participation varies as the study is ongoing and collects long-term results.
CONDITIONS
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
J
Jan Jenkins, RN
J
Joanne Davis, PHD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The Radiosurgery Society
Lead Sponsor
VisionTree
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Varies by condition being treated
Participants undergo stereotactic radiosurgery or stereotactic body radiation therapy (SRS/SBRT) specific to their condition being treated.
Duration - Up to 5 years
Participants are observed to track treatment outcomes including overall survival and recurrence for up to 5 years.
Periodic follow-up visits for outcome assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Joanne N Davis, Clinton Medbery, Sanjeev Sharma...
https://pubmed.ncbi.nlm.nih.gov/25774243/Raj Singh, Joanne Davis, Sanjeev Sharma
https://pubmed.ncbi.nlm.nih.gov/27182468/Joanne N Davis, Clinton Medbery, Sanjeev Sharma...
https://pubmed.ncbi.nlm.nih.gov/25975848/Joanne N Davis, Clinton Medbery, Sanjeev Sharma...
https://pubmed.ncbi.nlm.nih.gov/24274599/Berndt Wowra, Alexander Muacevic, Jörg-Christian Tonn
https://pubmed.ncbi.nlm.nih.gov/22236681/Anthony Ricco, Joanne Davis, William Rate...
https://pubmed.ncbi.nlm.nih.gov/28143558/Sonja Dieterich, Iris C Gibbs
https://pubmed.ncbi.nlm.nih.gov/21625154/Seil Sohn, Chun Kee Chung
https://pubmed.ncbi.nlm.nih.gov/22396835/Anand Mahadevan, Oliver Blanck, Rachelle Lanciano...
https://pubmed.ncbi.nlm.nih.gov/29439707/Joanne Davis, Sanjeev Sharma, Richard Shumway...
https://pubmed.ncbi.nlm.nih.gov/26798571/The Radiosurgery Society
Lead Sponsor
VisionTree
Collaborating Sponsor